O, K., K, K., O, D., J, R., A, B., BA, M., . . . S, S. (2005). Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: An imbalance between proinflammatory and antiinflammatory lipid mediators. Arthritis & Rheumatism, 52(12), 3783. https://doi.org/10.1002/art.21432
Chicago Style (17th ed.) CitationO, Kowal-Bielecka, Kowal K, Distler O, Rojewska J, Bodzenta-Lukaszyk A, Michel BA, Gay RE, Gay S, and Sierakowski S. "Cyclooxygenase- and Lipoxygenase-derived Eicosanoids in Bronchoalveolar Lavage Fluid from Patients with Scleroderma Lung Disease: An Imbalance Between Proinflammatory and Antiinflammatory Lipid Mediators." Arthritis & Rheumatism 52, no. 12 (2005): 3783. https://doi.org/10.1002/art.21432.
MLA (9th ed.) CitationO, Kowal-Bielecka, et al. "Cyclooxygenase- and Lipoxygenase-derived Eicosanoids in Bronchoalveolar Lavage Fluid from Patients with Scleroderma Lung Disease: An Imbalance Between Proinflammatory and Antiinflammatory Lipid Mediators." Arthritis & Rheumatism, vol. 52, no. 12, 2005, p. 3783, https://doi.org/10.1002/art.21432.